INTRODUCTION: The treatment of @entity418 remains clinically challenging because of the overall poor prognosis associated with the disease. The mortality rate associated with surgical treatment is high, and the majority of diagnosed @entity1 are old. As such, surgery is not possible in many cases, even when the @entity5 has progressed to a resectable state. CASE PRESENTATION: We present the case of an 82-year-old Korean @entity1 who presented to our institution with intermittent odynophagia. @entity418 with @entity3 and @entity3 to three regional lymph nodes was diagnosed. After neoadjuvant chemoradiotherapy, his regional lymph nodes disappeared. Because of his poor pulmonary function, surgical treatment could not be performed. Endoscopic submucosal dissection was carried out instead, and endoscopic @entity2713 injections were performed serially. Neither recurrence nor abnormal symptoms such as @entity1282 or regurgitation have developed for 36 months. CONCLUSIONS: The literature suggests that endoscopic submucosal dissection after chemoradiotherapy is a viable treatment modality in @entity1 with @entity418 with a high surgical treatment risk.

XXXX treated by endoscopic submucosal dissection after neoadjuvant chemoradiotherapy: a case report.

@entity1 :: ('9606', 'Species') :: ['patients', 'man'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity418 :: ('MESH:D004938', 'Disease') :: ['Esophageal cancer', 'esophageal cancer'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis', 'submucosal invasion'] @entity1282 :: ('MESH:D003680', 'Disease') :: ['dysphagia'] @entity2713 :: ('MESH:D014221', 'Chemical') :: ['triamcinolone']
@entity418 :: (MESH:D004938,Disease) :: ['Esophageal cancer']
